Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels. Individual contributing factors have been the focus of extensive research. As part of the Integrative Human Microbiome Project (HMP2 or iHMP), we followed 132 subjects for one year each to generate integrated longitudinal molecular profiles of host and microbial activity during disease (up to 24 time points each; in total 2,965 stool, biopsy, and blood specimens). Here we present the results, which provide a comprehensive view of functional dysbiosis in the gut microbiome during inflammatory bowel disease activity. We demonstrate a characteristic increase in facultative anaerobes at the expense of obligate anaerobes, as well as molecular disruptions in microbial transcription (for example, among clostridia), metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in host serum. Periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts. Finally, integrative analysis identified microbial, biochemical, and host factors central to this dysregulation. The study’s infrastructure resources, results, and data, which are available through the Inflammatory Bowel Disease Multi’omics Database ( http://ibdmdb.org ), provide the most comprehensive description to date of host and microbial activities in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This relative absence of biomarkers for active UC may result both from its generally more benign phenotype (IBDMDB Investigators et al., 2019) and from the smaller number of active UC samples (n = 23) compared with active CD samples (n = 76); as a result, we focused our subsequent analyses on expression differences within the CD subcohort.”
From Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 (2021) · cites this paper as IBDMDB Investigators et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This network of mechanistic associations identified several key components that are central to the alterations seen in IBD, highlighting octanoyl carnitine, several lipids and short-chain fatty acids, the taxa Faecalibacterium, Subdoligranulum, Roseburia, Alistipes, and Escherichia, some at both the metagenomic and metatranscriptomic levels, and host regulators of interleukins49.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Multiple lines of evidence point towards central roles of gut microbiome perturbations in the pathogenesis of IBD.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“These studies, which have now reached the first stage of completion49–51, together provide a wealth of information and insights about not only microbial dynamics, but also associated human host responses and microbial inter-relationships.”
From The Integrative Human Microbiome Project (2019) · cites this paper as [49]
In the citing paper
“The authors could then use the 17 top taxa in their ranked list to identify which individuals are dysbiotic, an approach that demonstrated similar or better performance than the GMWI2 or another published metric called the “dysbiotic score”.195”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [195]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationUPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Cited by
Items 901–1,000 of 1,010
Adversarial and variational autoencoders improve metagenomic binning
Líndez, P. P., Johansen, J., Kutuzova, S., Sigurdsson, A. I., Nissen, J. N., & Rasmussen, S. (2023) · Communications Biology · doi:10.1038/s42003-023-05452-3 · Cited by 33
Acupuncture influences multiple diseases by regulating gut microbiota
Xu, H., Luo, Y., Li, Q., & Zhu, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1371543 · Cited by 34
Chen, X., Feng, Y., Zhang, D., Zhou, S., Liu, X., Luo, B., Zhou, C., & Liu, M. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102669 · Cited by 31
A guide to reverse metabolomics—a framework for big data discovery strategy
Charron‐Lamoureux, V., Mannochio-Russo, H., Lamichhane, S., Xing, S., Patan, A., Gomes, P. W. P., Rajkumar, P., Deleray, V., Caraballo‐Rodríguez, A. M., Chua, K. V., et al. (2025) · Nature Protocols · doi:10.1038/s41596-024-01136-2 · Cited by 35
Aslam, H., Trakman, G., Dissanayake, T., Todd, E., Harrison, P., Alby, C., Jabeen, T., Gamage, E., Travica, N., Marshall, S., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07428-9 · Cited by 30
“A ss o c i - a t e d w i t h I B D [ 110 ] , p r o i n fl a mm a t i o n [ 111 ] a n d p a t h o g e n i c [ 112 ] .”
Sparse linear discriminant analysis for multiview structured data
Safo, S. E., Min, E. J., & Haine, L. (2021) · Biometrics · doi:10.1111/biom.13458 · Cited by 34
“Many applications exist that consider this important problem (Langley et al., 2013; Lloyd-Price et al., 2019).”
BackgroundAmbrożkiewicz, F., Karczmarski, J., Kulecka, M., Paziewska, A., Niemira, M., Żeber‐Lubecka, N., Zagórowicz, E., Kretowski, A. J., & Ostrowski, J. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01444-3 · Cited by 33
“reduces the levels of SCFAs and secondary bile acids, while enhancing the levels of primary bile acids [41].”
BackgroundResultInfluentialHMPDACC: a Human Microbiome Project Multi-omic data resource
Huot, H., Felix, V., Aluvathingal, J., Crabtree, J., Ifeonu, O. O., Matsumura, J., McCracken, C. L., Nickel, L., Orvis, J., Schor, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa996 · Cited by 41
“A 3-year second phase of the HMP, the Integrative Human Microbiome Project (iHMP), involved studies focusing on three particular conditions in human health (2,3): onset of Type 2 diabetes (4), inflammatory bowel disease (5) and pregnancy/pre-term birth (6).”
BackgroundThe Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
Elmaghrawy, K., Hussey, S., & Moran, G. P. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.620254 · Cited by 33
“In the case of CD, the trigger for this breakdown in homeostasis is unknown, but recent evidence suggests that environmental factors, host genetics and possibly oral-gut transit of microorganisms could all play a role in perturbation of the relationsip between the mucosal immune system and the gut microbiota (16, 17).”
BackgroundA Bacterial Inflammation Sensor Regulates c-di-GMP Signaling, Adhesion, and Biofilm Formation
Perkins, A., Tudorica, D. A., Teixeira, R. D., Schirmer, T., Zumwalt, L., Ogba, O. M., Cassidy, C. K., Stansfeld, P. J., & Guillemin, K. J. (2021) · mBio · doi:10.1128/mbio.00173-21 · Cited by 37
Helicobacter pylori and the intestinal microbiome among healthy school‐age children
Lapidot, Y., Reshef, L., Cohen, D., & Muhsen, K. (2021) · Helicobacter · doi:10.1111/hel.12854 · Cited by 31
Medel‐Matus, J., Lagishetty, V., Santana‐Gomez, C., Shin, D. H., Mowrey, W. B., Staba, R. J., Galanopoulou, A. S., Sankar, R., Jacobs, J. P., & Mazarati, A. M. (2022) · Epilepsia · doi:10.1111/epi.17248 · Cited by 34
Li, L., Yang, K., Li, C., Zhang, H., Yu, H., Chen, K., Yang, X., & Liu, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943325 · Cited by 39
“This knowledge gap can be addressed using whole-genome shotgun sequencing, which provides more in-depth taxonomic characterization and functional insights into human microbiomes (17).”
BackgroundClinical Significance of Lipid Transport Function of ABC Transporters in the Innate Immune System
Kotlyarov, S. N., & Котлярова, А. А. (2022) · Membranes · doi:10.3390/membranes12111083 · Cited by 38
Ferru-Clément, R., Boucher, G., Forest, A., Bouchard, B., Bitton, A., Lesage, S., Schumm, L. P., Lazarev, M. G., Brant, S. R., Duerr, R. H., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac281 · Cited by 31
Self-citationBosch, D. E., Abbasian, R., Parajuli, B., Peterson, S. B., & Mougous, J. D. (2023) · mBio · doi:10.1128/mbio.01039-23 · Cited by 39
“This Integrative Human Microbiome Project cohort included biweekly stool samples from 67 subjects with Crohn’s disease, 38 with UC, and 27 non-IBD controls (9).”
BackgroundMethodMicrobes with higher metabolic independence are enriched in human gut microbiomes under stressPreprint
Veseli, I., Chen, Y. T., Schechter, M. S., Vanni, C., Fogarty, E. C., Watson, A. R., Jabrì, B., Blekhman, R., Willis, A. D., Yu, M., et al. (2025) · eLife · doi:10.7554/elife.89862 · Cited by 58
“The marked decrease in microbial diversity in IBD is often associated with the loss of 50 Firmicutes populations and an increased representation of a relatively small number of taxa, such as Bacteroides, Enterococcaceae, and others (Prindiville et al. 2000; Saitoh et al. 2002; Sartor 2006; Rhodes 2007; Devkota et al.…”
Jia, X., Wu, B., Chen, B.-D., Li, K., Liu, Y., Xu, Y., Wang, J., & Zhang, X. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103050 · Cited by 30
Fongang, B., Satizábal, C. L., Kautz, T. F., Wadop, Y. N., Muhammad, J. A. S., Vasquez, E. L., Mathews, J. J., Gireud, M., Saklad, A. R., Himali, J. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40872-5 · Cited by 33
Schalich, K. M., Buendia, M. A., Kaur, H., Choksi, Y. A., Washington, M. K., Codreanu, G. S., Sherrod, S. D., MCLEAN, J. A. J., Peek, R. M., Acra, S. A., et al. (2024) · mBio · doi:10.1128/mbio.00298-24 · Cited by 37
“Notably, pantothenate levels are reduced in the gut of IBD patients (30).”
BackgroundFossmark, R., & Olaisen, M. (2024) · Microorganisms · doi:10.3390/microorganisms12061110 · Cited by 34
Leibovitzh, H., Nayeri, S., Borowski, K., Hernández-Rocha, C., Lee, S.-H., Turpin, W., Stempak, J. M., Sandhu, I., Milgrom, R., Smith, M. I., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae096 · Cited by 34
MIDASim: a fast and simple simulator for realistic microbiome data
He, M., Zhao, N., & Satten, G. A. (2024) · Microbiome · doi:10.1186/s40168-024-01822-z · Cited by 35
Junyi, L., Yueyang, W., Liu, B., Xiaohong, D., Wenhui, C., Zhang, N., & Zhang, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04513-w · Cited by 34
Profiling lateral gene transfer events in the human microbiome using WAAFLE
Hsu, T. Y., Nzabarushimana, É., Wong, D. H.-J., Luo, C., Beiko, R. G., Langille, M. G. I., Huttenhower, C., Nguyen, L. H., & Franzosa, E. A. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01881-w · Cited by 41
“These LGTs were selected from an additional dataset of 616 LGTs predicted from 26 assembled stool metagenomes from control participants in the HMP2 Inflammatory Bowel Disease Multi’omics Database (IBDMDB) cohort 42 for whom biospecimens were available for experimentation.”
Self-citationLearning a deep language model for microbiomes: The power of large scale unlabeled microbiome data
Pope, Q., Varma, R., Tataru, C. A., David, M. M., & Fern, X. Z. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011353 · Cited by 43
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites
Li, H., Pan, M., Li, Y., Cui, M., & Zhang, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.006 · Cited by 32
“Fecal propionate levels were lower in dysbiosis patients when compared to non-dysbiosis subjects, while the decrease in butyrate coincided well with the reduced abundance of butyrate-producing bacteria Thus, intestinal acetate, butyrate, and propionate levels were also changed[9].”
Pinto-Ribeiro, I., Ferreira, R. M., Pereira‐Marques, J., Pinto, V., Macedo, G., Carneiro, F., & Figueiredo, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031096 · Cited by 34
Grosse, C. S. J., Christophersen, C. T., Devine, A., & Lawrance, I. C. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1733413 · Cited by 37
“Certain secondary bile acids and large enrichment in acylcarnitine levels have recently been reported in a dysbiotic gut and associated with IBD [70].”
BackgroundInfluentialKoo, H., McFarland, B. C., Hakim, J. A., Crossman, D. K., Crowley, M. R., Rodriguez, J. M., Benveniste, E. N., & Morrow, C. D. (2020) · Royal Society Open Science · doi:10.1098/rsos.192200 · Cited by 29
“Ultimately, this analysis might provide new information for the linkage of inherited host gene diseases with dysbiosis in the gut microbial community [42,43].”
BackgroundDisturbance triggers non-linear microbe–environment feedbacks
Sengupta, A., Fansler, S. J., Chu, R., Danczak, R., Garayburu‐Caruso, V. A., Renteria, L., Song, H., Toyoda, J. G., Hager, J. R., & Stegen, J. (2021) · Biogeosciences · doi:10.5194/bg-18-4773-2021 · Cited by 32
Gu, Z., Zhu, Y., Mei, F., Dong, X., Xia, G., & Shen, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107802 · Cited by 30
Sakurai, T., Velasco, M. A. D., Sakai, K., Nagai, T., Nishiyama, H., Hashimoto, K., Uemura, H., Kawakami, H., Nakagawa, K., Ogata, H., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13062 · Cited by 30
Gut microbiome responses to dietary intervention with hypocholesterolemic vegetable oils
Lim, R. R. X., Park, M. A., Wong, L. H., Haldar, S., Lim, K. J., Nagarajan, N., Henry, C. J., Jiang, Y. R., & Moskvin, O. V. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00287-y · Cited by 29
Xia, B., Liu, X., Li, Z., Ren, J., & Liu, X. (2022) · Current Opinion in Food Science · doi:10.1016/j.cofs.2022.100956 · Cited by 37
Single sample pathway analysis in metabolomics: performance evaluation and application
Wieder, C., Lai, R., & Ebbels, T. M. D. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-05005-1 · Cited by 33
“Finally, we reproduced very similar results using a different semi-synthetic dataset based on data from Lloyd-Price et al., 2019 [23] (Fig.”
BackgroundMethodResultInfluentialYang, J. C., Jacobs, J. P., Hwang, M., Sabui, S., Liang, F., Said, H. M., & Skupsky, J. (2023) · Nutrients · doi:10.3390/nu15020264 · Cited by 32
Guo, W., Tang, X., Zhang, Q., Zhao, J., Mao, B., Zhang, H., & Cui, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813852 · Cited by 33
“In IBD patients, the gut microbiota composition is altered [8].”
BackgroundBourgonje, A. R., van Goor, H., Faber, K. N., & Dijkstra, G. D. H. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000579 · Cited by 31
“advances have facilitated the integration of big data, enabling the establishment of molecular constructs that are specific to IBD (11,12).”
Kim, K. S., Tiffany, E., Lee, J., Oh, A., Jin, H., Kim, J.-S., Lee, J., Nam, M. H., Hong, S., Park, S., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221811 · Cited by 29
Pan, L., Ma, M., Wang, Y., Dai, W., Fu, T., Wang, L., Shang, Q., & Yu, G. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128592 · Cited by 30
Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease
Hertz, S., Anderson, J. M., Nielsen, H. L., Schachtschneider, C., McCauley, K. E., Özçam, M., Larsen, L., Lynch, S. V., & Nielsen, H. I. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2338244 · Cited by 30
Jin, X., Li, H., Pan, S., Song, B., Jiang, Y., Shi, H., Zhang, J., Chu, B., Wang, H., & He, Y. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c12139 · Cited by 30
Hazime, H., Ducasa, G. M., Santander, A. M., Brito, N., Gonzalez-Horta, E. E., Quintero, M. A., Barnes, S., Wilson, L. S., Zhang, Y., Yu, F., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334346 · Cited by 32
“8 We recently demonstrated that colonic epithelial cells (CECs) activate DUOX2 in response to adherent, invasive Escherichia coli (AIEC, phylum Proteobacteria ), 14 an IBD pathobiont, but not in response to Faecalibacte-rium prausnitzii (phylum Firmicutes ), 14 21 a butyrate-producing commensal.”
Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids
Fitzgerald, B. G., Govind, M., Firth, I. J., Herold, L., Froment, J., Vancuren, S. J., Allen‐Vercoe, E., Kimber, M. S., & Sorbara, M. T. (2025) · Microbiome · doi:10.1186/s40168-025-02220-9 · Cited by 41
“16S rRNA abundance data was downloaded from the iHMP data [32, 33] portal along with the associated meta-data.”
InfluentialPaciolla, C., Manganelli, M., Chiano, M. D., Montenegro, F., Gallone, A., Sallustio, F., & Guida, G. (2025) · Cells · doi:10.3390/cells14221823 · Cited by 42
Ecological Structuring of Temperate Bacteriophages in the Inflammatory Bowel Disease-Affected Gut
Nishiyama, H., Endo, H., Blanc‐Mathieu, R., & Ogata, H. (2020) · Microorganisms · doi:10.3390/microorganisms8111663 · Cited by 36
“Non-IBD patients had gastrointestinal symptoms but were not diagnosed with IBD [1].”
BackgroundMethodResultInfluentialEverett, C., Li, C., Wilkinson, J. E., Nguyen, L. H., McIver, L. J., Ivey, K. L., Izard, J., Palacios, N., Eliassen, A. H., Willett, W. C., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00519-z · Cited by 29
Self-citationDeshpande, N., Riordan, S. M., Gorman, C. J., Nielsen, S. J., Russell, T., Correa-Ospina, C., Fernando, S., Waters, S. A., Castaño‐Rodríguez, N., Man, S. M., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00951-6 · Cited by 33
“utilized effectively to identify factors central to disease etiology [12].”
The oral microbiome in relation to pancreatic cancer risk in African Americans
Petrick, J. L., Wilkinson, J. E., Michaud, D. S., Cai, Q., Gerlovin, H., Signorello, L. B., Wolpin, B. M., Ruiz-Narváez, E., Long, J., Yang, Y., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01578-5 · Cited by 29
Self-citationLiso, M., Sila, A., Verna, G., Scarano, A., Donghia, R., Castellana, F., Cavalcanti, E., Pesole, P. L., Sommella, E., Lippolis, A., et al. (2022) · Antioxidants · doi:10.3390/antiox11010138 · Cited by 30
Metaproteomics as a tool for studying the protein landscape of human-gut bacterial species
Stamboulian, M. H., Canderan, J., & Ye, Y. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009397 · Cited by 29
Jacobs, J. P., Goudarzi, M., Lagishetty, V., Li, D., Mak, T. D., Tong, M., Ruegger, P. M., Haritunians, T., Landers, C. J., Fleshner, P. R., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01099-7 · Cited by 30
“These findings suggest a reduction in bacterial transformation of primary to secondary bile acids and are consistent with a recent fecal metabolomics study reporting increased cholate and decreased deoxycholate in CD patients with dysbiosis as well as findings from preclinical models of intestinal injury [19, 106].”
ResultSelf-citationJanker, L., Schuster, D., Bortel, P., Hagn, G., Meier, S. M., Mohr, T. T., Mader, J. C., Slany, A., Bileck, A., Brunmair, J., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad052 · Cited by 28
Infection leaves a genetic and functional mark on the gut population of a commensal bacterium
Tawk, C., Lim, B., Bencivenga-Barry, N. A., Lees, H., Ramos, R. J. F., Cross, J. R., & Goodman, A. L. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.005 · Cited by 30
A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases
Qi, C., Wang, P., Fu, T., Lu, M., Cai, Y., Chen, X., & Cheng, L. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elaa029 · Cited by 29
Liu, P., Wu, W., Chen, C., Panyod, S., Sheen, L., & Wu, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256818 · Cited by 44
“4 INTRODUCTION 56 The human microbiome affects human health in numerous ways (1-7).”
BackgroundMethodBenchmarking microbial DNA enrichment protocols from human intestinal biopsies
Marchukov, D., Li, J., Juillerat, P., Misselwitz, B., & Yılmaz, B. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1184473 · Cited by 31
“Changes in the gut microbiota have been associated with a wide range of diseases, including inflammatory bowel diseases (IBD) (Lloyd-Price et al., 2019; Yilmaz et al., 2019), celiac diseases (Olivares et al.”
BackgroundIntestinal microbiome and metabolome signatures in patients with chronic granulomatous disease
Chandrasekaran, P., Han, Y., Zerbe, C. S., Heller, T., Ravin, S. S. D., Kreuzberg, S. A., Marciano, B. E., Siu, Y., Jones, D. R., Abraham, R. S., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.022 · Cited by 30
Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease
Chen, W., Wang, D., Deng, X., Zhang, H., Dong, D., Su, T., Lu, Q., Jiang, C., Ni, Q., Cui, Y., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323231 · Cited by 31
“14,15 While previous mul-tiomics studies have compared individuals with IBD and healthy controls, and patients with the CD and UC subtypes, 16–18 insufficient attention has been given to the variance in different activity stages, particularly in children.”
BackgroundGut microbiome composition and metabolic activity in women with diverticulitis
Ma, W., Wang, Y., Nguyen, L. H., Mehta, R. S., Ha, J., Bhosle, A., Mclver, L. J., Song, M., Clish, C. B., Strate, L. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47859-4 · Cited by 36
Self-citationWang, X., Lang, F., & Liu, D. (2024) · Biology · doi:10.3390/biology13090674 · Cited by 36
“In addition, in a multi-omics analysis of the gut microbial community in IBD, Lloyd-Price J. et al. observed a reduction in SCFAs, particularly butyrate, in IBD patients with dysbiosis samples compared to non-dysbiotic samples with IBD [39].”
BackgroundCrouch, L. I., Rodrigues, C. S., Bakshani, C. R., Tavares-Gomes, L., Gaifem, J., & Pinho, S. S. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101891 · Cited by 31
Jamerlan, A., An, S. S. A., & Hulme, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2486518 · Cited by 40
Microbiota-dependent metabolites – New engine for T cell warriors
Tang, Y., Fu, A., Wang, L., & Ge, Q. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2523815 · Cited by 31
“50,51,127 In IBD patients, some secondary BAs as well as the bacterial genes required for their biosynthesis such as 3α-hydroxysteroid dehydrogenase gene are significantly reduced.”
Cause or effect? The spatial organization of pathogens and the gut microbiota in disease
Nguyen, J., Pepin, D. M., & Tropini, C. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104815 · Cited by 29
Bamba, S., Inatomi, O., Nishida, A., Ohno, M., Imai, T., Takahashi, K., Naito, Y., Iwamoto, J., Honda, A., Inohara, N., et al. (2021) · Intestinal Research · doi:10.5217/ir.2021.00054 · Cited by 28
“A recent multi-omics study showed functional dysbiosis in the gut microbiome of IBD patients, which is characterized by molecular disruption of microbial transcription, metabolite pools (acylcarnitines, bile acids, and short-chain fatty acids), and antibodies in host serum.(13) Bile acids are metabolized by the gut mi…”
BackgroundKey Technologies for Progressing Discovery of Microbiome-Based Medicines
Young, R. B., Marcelino, V. R., Chonwerawong, M., Gulliver, E. L., & Forster, S. C. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.685935 · Cited by 30
“Both ascorbate and aldarate metabolism, and amino sugar, nucleotide sugar metabolism, fructose and other metabolic pathways were identified to have a greater contribution to IBD samples.”
BackgroundInfluentialGraphOmics: an interactive platform to explore and integrate multi-omics data
Wandy, J., & Daly, R. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04500-1 · Cited by 31
Oldoni, E., Saunders, G. I., Biétrix, F., García‐Bermejo, L., Niehues, A., Hoen, P. A. C. ’., Nordlund, J., Hajdúch, M., Scherer, A., Kivinen, K., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.974799 · Cited by 33
Wang, J., Xiang, Q., Gu, S., Gu, Y., Yao, M., Huang, W., Wang, G., & Tang, L. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s388687 · Cited by 29
“Previous studies have demonstrated that substantial reductions in the abundance of Bacteroidetes, an important producer of short-chain fatty acids, have been associated with intestinal inflammation and various other pathological states.(32,33) On the contrary, a normal gut microbiome dominated by Firmicutes and Bacter…”
ResultGut microbiome profile of Chinese hypertension patients with and without type 2 diabetes mellitus
Ding, H., Xu, Y., Cheng, Y., Zhou, H., Dong, S., Wu, J. F., Lv, J., Hu, X., & Tang, O. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02967-x · Cited by 26
“Many studies have already demonstrated the altered microbiota composition in patients with digestive diseases, including inflammatory bowel diseases [6] and irritable bowel syndrome [7].”
BackgroundMetabolomics in the era of artificial intelligence
Coler, E., Chen, W., Melnik, A. V., Morton, J. T., & Aksenov, A. A. (2024) · Microbiota and Host · doi:10.1530/mah-23-0017 · Cited by 35
Pedrogo, D. A. M., Sears, C. L., & Melia, J. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae061 · Cited by 32
Gray, S. M., Moss, A. D., Herzog, J., Kashiwagi, S., Liu, B., Young, J. B., Sun, S., Bhatt, A. P., Fodor, A. A., & Sartor, R. B. (2024) · Microbiome · doi:10.1186/s40168-024-01857-2 · Cited by 28
“Large interindividual variability of human donor microbiota likely exacerbates this phenomenon in HMA murine studies [8, 57, 61].”
BackgroundMicrobiota-derived metabolites in inflammatory bowel disease
Guggeis, M. A., Harris, D. M. M., Welz, L., Rosenstiel, P. C., & Aden, K. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01046-9 · Cited by 35
“In this case, dysbiosis was defined by a large deviation from the taxonomic composition of the non-IBD samples: as this was a longitudinal study, dysbiotic periods could be identified longitudinally within individual IBD patients [50].”
Gut microbiome evolution from infancy to 8 years of age
Sawhney, S. S., Thänert, R., Thänert, A., Hall-Moore, C. M., Ndao, I. M., Mahmud, B., Warner, B. B., Tarr, P. I., & Dantas, G. A. (2025) · Nature Medicine · doi:10.1038/s41591-025-03610-0 · Cited by 34
“A scaffold-to-bin (stb) mapping file was then generated using dRep (version 3.2.2; work-flow: parse_stb.py; flags: –reverse), and TS-specific short reads were aligned against the reference RG multifasta for each timepoint within an individual using Bowtie 2 (version 2.3.5).”
InfluentialLiu, W., Wang, L., Ou, J., Peng, D., Zhang, Y., Chen, W., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083752 · Cited by 39
“A clinical study involving 132 participants over one year revealed that IBD onset coincided with gut microbiota dysbiosis [109].”
Novel cross-feeding human gut microbes metabolizing tryptophan to indole-3-propionate
Zünd, J. N., Mujezinovic, D., Reichlin, M., Plüss, S., Caflisch, M., Robinson, S. L., Lacroix, C., & Pugin, B. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2501195 · Cited by 37
Tryptophan metabolism and the intestinal microbiota: Implications for inflammatory bowel disease
Hua, X., Chen, Y., Ding, S., & Fang, J. Q. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128280 · Cited by 32
Tezé, D., Shuoker, B., Chaberski, E. K., Kunstmann, S., Fredslund, F., Nielsen, T. S., Stender, E. G. P., Peters, G. H. J., Karlsson, E. N., Welner, D. H., et al. (2020) · ACS Catalysis · doi:10.1021/acscatal.9b04474 · Cited by 25
Kundra, P., Rachmühl, C., Lacroix, C., & Geirnaert, A. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901271 · Cited by 27
Zhuang, X., Tian, Z., Li, N., Mao, R., Li, X., Zhao, M., Xiong, S., Zeng, Z., Feng, R., & Chen, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.615858 · Cited by 28
“2 Ileocolonic resection 6m Endoscopic recurrence Rutgeerts score Steroids (15), Biologic therapy (22), 5-ASA (6), AZA (17), MTX (5) Steroid (2), Biologic therapy (25), 5-ASA (5), AZA (16), MTX (3), Antibiotics (18) 6m 6 m: 33.”
BackgroundShi, Y., Zhong, L. X., Li, Y., Chen, Y., Feng, S., Wang, M., Xia, Y. Y., & Tang, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.648915 · Cited by 27
“In addition to the environmental, genetic, and immune factors, dysbiosis of microbiota has been found to contribute to the initiation and development of IBD (Aschard et al., 2019; Lloyd-Price et al., 2019; Ansari et al., 2020).”
BackgroundTran, A., Scholtes, C., Songane, M., Champagne, C., Galarneau, L., Levasseur, M.-P., Fodil, N., Dufour, C. R., Giguère, V., & Saleh, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94499-5 · Cited by 27
Krishna, M., Engevik, M. A., Queliza, K., Britto, S. L., Shah, R., Ruan, W. H., Wang, H., Versalovic, J. A., & Kellermayer, R. (2021) · FASEB BioAdvances · doi:10.1096/fba.2021-00078 · Cited by 27
Ren, R., Gao, X., Shi, Y., Li, J., Peng, L., Sun, G., Wang, Z., Yan, B., Zhi, J., & Yang, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.742255 · Cited by 27
“were significantly increased in UC patients receiving FMT, agreeing with some previous studies (Lopez-Siles et al., 2017; Nishino et al., 2018; Lloyd-Price et al., 2019).”
BackgroundResultTailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
Sudhakar, P., Alsoud, D., Wellens, J., Verstockt, S., Arnauts, K., Verstockt, B., & Vermeire, S. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac027 · Cited by 28
Chen, H., Li, Y., Xie, X., Chen, M., Xue, L., Wang, J., Ye, Q., Wu, S., Yang, R., Zhao, H. J., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.838060 · Cited by 26
“Nicotinamide mononucleotide transporter can directly transport extracellular NMN into the cell and increase the level of NAM, thereby regulating NAD metabolism (Wu and Sinclair, 2019; Lloyd-Price et al., 2019; Yachida et al., 2019).”
Backgroundvan der Lugt, B., Vos, M. C. P., Bromhaar, M. G., Ijssennagger, N., Vrieling, F., Meijerink, J., & Steegenga, W. T. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08883 · Cited by 28
Jiang, S., Chen, D., Ma, C., Liu, H., Huang, S. W., & Zhang, J. (2022) · iMeta · doi:10.1002/imt2.40 · Cited by 28
“We also collected public IBD datasets for secondary verification, including datasets PRJNA398089 [15] and ERP002061 [16].”
MethodBeura, S., Kundu, P., Das, A. K., & Ghosh, A. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105997 · Cited by 28
Elmaghrawy, K., Fleming, P., FitzGerald, K., Cooper, S., Dominik, A., Hussey, S., & Moran, G. P. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac155 · Cited by 32
Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitis
Baumgartner, M., Zirnbauer, R., Schlager, S., Mertens, D., Gasche, N., Sladek, B., Herbold, C. W., Bochkareva, O., Emelianenko, V., Vogelsang, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2143218 · Cited by 27
“It might be explained by depleted mucin production, preexisting low-grade colonic inflammation or altered microbiome diversity.(8,59) The modest sample size of our isolated strains is a limitation of this study.”
BackgroundCold stress induces colitis-like phenotypes in mice by altering gut microbiota and metabolites
Sun, L., Wang, X., Zou, Y., He, Y., Liang, C., Li, J., Li, P., & Zhang, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1134246 · Cited by 32
“org and function are disturbed seriously, including bile acids, short-chain fatty acids, and tryptophan (Lloyd-Price et al., 2019; Lavelle and Sokol, 2020).”
BackgroundThe role of faecal microbiota transplantation in chronic noncommunicable disorders
Mullish, B. H., Tohumcu, E., Porcari, S., Fiorani, M., Tommaso, N. D., Gasbarrini, A., Cammarota, G., Ponziani, F. R., & Ianiro, G. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103034 · Cited by 26
The Integrative Human microbiome project: a mile stone in the understanding of the gut microbiome
Voth, E. R., & Khanna, S. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1780912 · Cited by 26
Sun, Y., Xu, J., Zhao, H., Li, Y., Zhang, H., Yang, B., & Guo, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1088949 · Cited by 27
“Meanwhile, IBD is a chronic, progressive, and recurrent bowel disease, and one of its main causative factors is the high levels of free radicals and low antioxidant capacity (51, 52).”
BackgroundCurrent Landscape and Evolving Therapies for Primary Biliary Cholangitis
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13181580 · Cited by 31
“Therefore, a decrease in butyrate-producing bacteria could result in impaired MDSC function and a suboptimal response to UDCA treatment, suggesting that microbiota-targeted therapies could have therapeutic potential in PBC patients.”
BackgroundNing, S., Zhang, Z., Zhou, C., Wang, B., Liu, Z., & Feng, B. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1457218 · Cited by 33
“The current hypothesis suggests that a decrease in Firmicutes serves as a protective factor for IBD, whereas an increase in Proteobacteria acts as an invasive factor (5, 14).”
Background
Metadata
- Authors
- Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., Rahnavard, G., Sauk, J., Shungin, D., Vázquez-Baeza, Y., White, R. A., IBDMDB Investigators, Bishai, J., Bullock, K., Deik, A., Dennis, C., Kaplan, J. L., Khalili, H., McIver, L. J., Moran, C. J., Nguyen, L., Pierce, K. A., Schwager, R., Sirota-Madi, A., Stevens, B. W., Tan, W., ten Hoeve, J. J., Weingart, G., Wilson, R. G., Yajnik, V., Braun, J., Denson, L. A., Jansson, J. K., Knight, R., Kugathasan, S., McGovern, D. P. B., Petrosino, J. F., Stappenbeck, T. S., Winter, H. S., Clish, C. B., Franzosa, E. A., Vlamakis, H., Xavier, R. J., & Huttenhower, C.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- Pacific Northwest National Laboratory (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Emory University (US)
- University of California San Diego (US)
- Washington University in St. Louis (US)
- Corresponding author
- Huttenhower, Curtis
- ORCID
- Arze, Cesar
- Ananthakrishnan, Ashwin N.
- Schirmer, Melanie
- Ajami, Nadim J.
- Bonham, Kevin S.
- Brislawn, Colin J.
- Casero, David
- Graeber, Thomas G.
- Hall, A. Brantley
- Mallick, Himel
- Plichta, Damian R.
- Sauk, Jenny
- Shungin, Dmitry
- Bullock, Kevin
- Deik, Amy
- Khalili, Hamed
- McIver, Lauren J.
- Nguyen, Long
- Pierce, Kerry A.
- Yajnik, Vijay
- Knight, Rob
- McGovern, Dermot P. B.
- Winter, Harland S.
- Clish, Clary B.
- Franzosa, Eric A.
- Vlamakis, Hera
- Xavier, Ramnik J.
- Huttenhower, Curtis
- Venue
- Nature
- Published
- 2019-05-29
- Volume
- 569
- Issue
- 7758
- Pages
- 655-662
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6650278
- OpenAlex
- W2947189704
- Cited by
- 3,143
- References
- 101
- Citations by year
- 2026: 500 · 2025: 555 · 2024: 498 · 2023: 402 · 2022: 441 · 2021: 452 · 2020: 247 · 2019: 42
- FWCI
- 98.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1053486, DEAC05–76RL01830, 76RL01830)
- U.S. Department of Energy (DE-AC05–76RL01830, 76RL01830, AC05-76RL01830, DE-AC05?)
- Battelle (AC05-76RL01830, DE- AC05-76RL01830, DE-AC05)
- Leona M. and Harry B. Helmsley Charitable Trust (P01DK046763, U01DK062413)
- Harvard T.H. Chan School of Public Health
- Crohn's and Colitis Foundation (563526)
- Broad Institute
- Vetenskapsrådet (4.1-2016-00416)
- National Institutes of Health (DBI-1053486, UL1TR001881, DE-AC05-76RL01830)
- National Human Genome Research Institute (R01HG005969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, R24DK110499, U54DK102557, U01DK062413, P30DK078392, P30DK043351, P30DK040561)
- National Institute of Dental and Craniofacial Research (U54DE023798)
- National Center for Advancing Translational Sciences
- Army Research Office (W911NF-11-1-0473, W911NF, W911NF-11)
- Pacific Northwest National Laboratory (DEAC0576RL01830, 76RL01830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut microbiota, dysbiosis, multi-omics, facultative anaerobes, obligate anaerobes, Clostridia, acylcarnitines, bile acids, short-chain fatty acids, serum antibodies, disease activity, temporal variation, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fungi, Health, Humans, Phylogeny, Species Specificity, Viruses, Inflammatory Bowel Diseases, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.